Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, for the Treatment of Obesity in People With Type 2 Diabetes (ATTAIN-2): A Phase 3, Double-Blind, Randomised, Multicentre, Placebo-Controlled Trial
This triggers dopamine release in the mesolimbic reward system and activates oxytocinergic neurons, producing both the psychological desire ("wanting") and the physical arousal response (Hadley, 2005)
Improved Iron Absorption Vitamin C increases iron uptakeespecially important for those with anemia, low iron, or heavy menstrual cycles
Incluso niveles bajos de amonaco pueden tener una toxicidad significativa
[PUBMED Abstract] Dummer R, Hauschild A, Santinami M, et al.: Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma
Obesity (Silver Spring, Md) 2017;25(8):13491359